InvestorsHub Logo
Followers 78
Posts 24617
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Thursday, 05/02/2024 8:45:16 AM

Thursday, May 02, 2024 8:45:16 AM

Post# of 27533
ALLR - 2.97/2.98 Up from 1.37

Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.